Back
Cyclerion Therapeutics, Inc. 10K Form
Sell
13
CYCN
Cyclerion Therapeutics, Inc.
Last Price:
$1.21
Seasonality Move:
-16.84%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CYCN News And Ratings
See the #1 stock for the next 7 days that we like better than CYCN
CYCN Financial Statistics
Sales & Book Value
| Annual Sales: | $2M |
|---|---|
| Cash Flow: | $-264K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.58 |
| Price / Book: | 0.54 |
Profitability
| EPS (TTM): | -0.75900 |
|---|---|
| Net Income (TTM): | $-2.2M |
| Gross Margin: | $0 |
| Return on Equity: | -25.03% |
| Return on Assets: | -22.86% |
Cyclerion Therapeutics, Inc. Earnings Forecast
Key Cyclerion Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 9 years for CYCN is 0.00%.
-
The Selling, General & Administrative Expenses for CYCN have been equal to 267.10% of Gross Profit Margin.
-
The Research & Development expenses have been 14.30% of Revenue.
-
The Net Earning history of CYCN is -152.85% of Total Revenues.
-
Per Share Earnings over the last 9 years have been positive in 5 years.
Cyclerion Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CYCN |
| Website: | cyclerion.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 5.78 |
| Quick Ratio: | 5.32 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CYCN Technical Analysis vs Fundamental Analysis
Sell
13
Cyclerion Therapeutics, Inc. (CYCN)
is a Sell
Is Cyclerion Therapeutics, Inc. a Buy or a Sell?
-
Cyclerion Therapeutics, Inc. stock is rated a SellThe current Cyclerion Therapeutics, Inc. [CYCN] share price is $1.20. The Score for CYCN is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.